Novak Djokovic is the controlling shareholder in a Danish biotech agency aiming to develop a therapy for Covid-19 that doesn’t contain vaccination, it has emerged.
The world No 1, who was deported from Australia this week after the federal government cancelled his visa in a dispute over a medical exemption regarding his unvaccinated standing, purchased an 80% stake in QuantBioRes in 2020.
Ivan Loncarevic, the corporate’s chief govt, confirmed the funding to Reuters. He subsequently advised the Monetary Instances that he had not spoken to Djokovic, who has won more than $150m in prize money, since November and that the tennis star was “not anti-vax”.
Djokovic flew out of Australia on Sunday after shedding a authorized problem to overturn the cancellation of his visa by Alex Hawke, the nation’s immigration minister, who mentioned Djokovic’s presence in Australia might risk “civil unrest” as he was a “talisman of anti-vaccination sentiment”.
QuantBioRes has about 11 researchers working in Denmark, Australia and Slovenia, in line with Loncarevic, who pressured the corporate was engaged on a therapy, not a vaccine. The corporate’s web site says it began growing a “deactivation mechanism” for Covid-19 in July 2020.
Djokovic, who can also be barred from defending his French Open title in Roland Garros in Could after the French authorities dominated on Monday that all athletes will have to be vaccinated so as to attend and compete in sporting occasions, acquired his stake within the firm in June 2020.
The corporate is growing a peptide, which inhibits the coronavirus from infecting the human cell, and it expects to launch scientific trials in Britain this summer season, Loncarevic mentioned.
A spokesperson for Djokovic didn’t instantly reply to a request for remark.